Microfluidic Manufacture of Lipid-Based Nanomedicines

Nanoparticulate technologies have revolutionized drug delivery allowing for passive and active targeting, altered biodistribution, controlled drug release (temporospatial or triggered), enhanced stability, improved solubilization capacity, and a reduction in dose and adverse effects. However, their...

Descripción completa

Detalles Bibliográficos
Autores principales: Osouli-Bostanabad, Karim, Puliga, Sara, Serrano, Dolores R., Bucchi, Andrea, Halbert, Gavin, Lalatsa, Aikaterini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506151/
https://www.ncbi.nlm.nih.gov/pubmed/36145688
http://dx.doi.org/10.3390/pharmaceutics14091940

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506151/
https://www.ncbi.nlm.nih.gov/pubmed/36145688
http://dx.doi.org/10.3390/pharmaceutics14091940

Ejemplares similares